Skip to main content
Premium Trial:

Request an Annual Quote

Teaching Congress a Thing (or Ten)

This blog post follows up on an article in the Washington Post about the long road that lies ahead for companies hoping to gain approval for biogenerics. The article follows Insmed's CEO, Geoffrey Allan, who has been advising Congress on drug pharmacology in order to speed up the approval process. "However, the applicant must provide evidence that its product will produce the same clinical result as the brand product in any given patient and that it presents no additional safety risks or diminished efficacy if a patient alternates or is switched between products. This will be a tough road to travel," says a post at Patent Baristas.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.